Search for an ETF or holding
Drugs Made In America Acquisiti (DMAA) is an American company in the financial services sector, listed on NASDAQ. Market capitalization of 258 million USD (micro-cap).
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.